GlassScriptPhysician profile
Connor Diaz
NPI 1669112876
$3,973.24
in general payments reported to CMS, 2019-2025
9 companies · $2,437 in 2025
The $2,437 reported for 2025 was more than what 95% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $177 · 2023: $325 · 2024: $1,035 · 2025: $2,437.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,649 · Travel and Lodging: $1,147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,649.18 |
| Travel and Lodging | $1,147.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,514.38 | 2024-2025 | Comprehensive Shoulder System, Persona |
| Stryker Corporation | $865.04 | 2022-2025 | Inbone, Citrefix, T2 |
| Coastal Medical Technologies LLC | $814.61 | 2024-2025 | |
| Polynovo North America LLC | $272.89 | 2024-2025 | Novosorb Btm |
| Medical Device Business Services, INC. | $220.83 | 2024-2025 | Vistaseal, Na, Actis |
| Depuy Synthes Sales INC. | $149.97 | 2024 | Teligen |
| Integra Lifesciences Corporation | $69.47 | 2022 | |
| Arthrex, INC. | $42.73 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $23.32 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Connor Diaz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.